Purpose: To start a patient on a bedtime insulin, daytime oral agent (BIDO) regimen for mild hyperglycemia.
A BIDO regimen (bedtime insulin, daytime oral agent) may be used by a patient who is still hyperglycemic while receiving an oral hypoglycemic agent.
To read more or access our algorithms and calculators, please log in or register.
Specialty: Endocrinology, Clinical Laboratory
Objective: dosage adjustments